Ridgepost Capital: The Market Is Still Pricing the SPAC, Not the Platform

The stock jumped 9.4% on Q2 earnings, then gave most of it back. That's the signature of a market that doesn't know which story it's in yet — the one where Ridgepost Capital is a leveraged SPAC that needs to prove itself, or the one where it's a $50 billion alternative-asset platform quietly compounding its fee machine.

The numbers from the second quarter suggest the latter is already underway. The tape hasn't caught up.

What actually changed

Fee-paying assets under management — the capital that generates recurring fees, distinct from total AUM that includes uninvested reserves — reached $34.3 billion. That's up 19% year-over-year, after compounding at roughly a 20% annual rate through Q2. Total AUM crossed $50 billion for the first time, more than $10 billion higher than a year ago.

Fee-related revenue, the core recurring income from management and advisory fees, was $81 million, up 11%. Fee-related earnings (FRE) — the operating profit those fees generate before the noise of one-time charges and acquisition integration costs — came in at $39 million, a 10% increase. The FRE margin was 48%.

Management and advisory fees accounted for 98.8% of fee revenue. For the trailing twelve months through June, fee-related revenue represented 99% of total revenue. This is a business whose income stream is nearly pure recurring fee — a durable structure in an industry still fighting for that label.

Then there's the Stellus Capital Management acquisition, completed June 22. Ridgepost paid roughly $250 million for a 20-year-old direct lender in the lower-middle market, adding $3.8 billion in AUM and $2.6 billion in fee-paying AUM. Management estimates Stellus could eventually pull in $500 million to $1 billion in incremental annual commitments from Ridgepost's GP network. That's a multi-year build, not a near-term boost — Stellus just closed a $1.5 billion fundraising cycle and is focused on deployment, not raising new capital.

The margin problem

Here's where the setup gets more interesting. Management left full-year 2026 FRE margin guidance in the mid-40s, despite the Q2 result sitting at 48%. They flagged placement agent costs and fundraising-related hiring in the back half as headwinds. That's the normal friction of a growing platform, but it also means the margin story isn't a straight line.

The tax picture adds pressure. Net operating loss carryforwards are being fully used up by year-end 2026. The cash tax rate is expected to move from high single-digits to low double-digits in 2026, then into the mid-teens in 2027. That's a structural drag on net income that most readers won't see until the numbers land.

Free cash flow: the hard proof

TTM free cash flow was $53.1 million. Down 7% year-over-year, which tracks with the Stellus integration costs and hiring ramp. But operating cash flow of $55.8 million against capex of just $2.7 million shows the underlying machine is capital-light. The $53 million FCF number is the current floor, not the trajectory.

Fre margins of 48% on $81 million in quarterly fee revenue imply roughly $156 million of annualized FRE, assuming no margin erosion. Even at mid-40s margins — management's full-year guidance — that annualizes to around $135 million in FRE. If Stellus integration runs smoothly and fee rates hold near their guided 103 basis points, FRE above $150 million is a credible next-12-month target.

The debt picture is the open question. Total debt stands at roughly $506 million against $29 million in cash, giving net debt of about $346 million. The leverage ratio is approximately 2.8 times EBITDA, above the stated target of mid-2x. Management paid down $20 million on the revolver after quarter-end and said deleveraging continues as cash flow permits. At the FCF run rate, that's roughly one year of cash flow to wipe out net debt — if integration costs don't eat it.

Why the market is still anchored to the old story

Ridgepost was P10, Inc. a SPAC that rebranded in February and began trading under the RPC ticker. The old narrative — speculative vehicle, leverage risk, identity uncertainty — is baked into how investors process the name. The stock is down 28% over the trailing twelve months and 8% year-to-date, despite AUM compounding at 20% and fee earnings growing 10%.

The valuation reflects that disconnect. At $8.99 today, the stock trades at 62.7x forward earnings and 3.25x trailing sales. Those multiples look stretched if you're pricing a leveraged SPAC trying to prove it has durable operations. They look tolerable if you're pricing a fee platform compounding AUM at 20% with nearly 100% recurring revenue and a path to mid-40s FRE margins.

AInvest's aggregate signal labels the stock a Buy, with a fundamental rating of 5.37 out of 10. That's a lukewarm endorsement — enough to say the financials aren't ugly, but not enough conviction to price in the rerating.

The financial bridge

Here's the setup: if FRE runs at $150 million annually and the market assigns even a modest 15x multiple to those fee earnings — well below the multiples faster-growing asset managers trade at — implied equity value sits around $2.25 billion. Against the current $991 million market cap, that's a 128% upside.

That math assumes three things hold: fee-paying AUM growth stays above 15%, FRE margins stabilize in the mid-40s despite the H2 headwind, and debt is cut from $506 million toward the mid-2x target. If any of those break, the bridge collapses.

The dividend — $0.04 per share, raised for four consecutive years — gives a 1.7% yield at current levels. It's not a reason to buy, but it is a signal that management isn't in survival mode.

The tripwire

The case breaks if fee-paying AUM growth falls below 10% in two consecutive quarters, or if H2 margin compression pushes full-year FRE margins below 38%. Either one would suggest the Stellus integration is heavier than modeled or the fee machine is stalling.

The debt level is the second tripwire. If net debt doesn't show meaningful reduction by Q4 — we'd want to see it below $250 million — the leverage risk returns to the foreground and the rerating thesis loses its footing.

Discipline over ego. The setup is improving underneath a tape that still remembers the SPAC. Whether that changes depends on whether the next two quarters prove management can absorb Stellus without breaking the margin machine.